Syros Pharmaceuticals Inc. (SYRS)
Market Closed
19 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
LSE $
0. 00
-0
-75%
$
10.73K Market Cap
4.89 P/E Ratio
- Div Yield
6,918 Volume
-4.76 Eps
$ 0
Previous Close Analysts:
Want to track SYRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Syros Pharmaceuticals Inc. (SYRS) Statistics
Valuation metrics
Market Cap 10.73K
Enterprise value -77.45M
Trailing P/E (ttm) -0
Forward P/E -0
PEG ratio 0
Price/Sales (ttm) 0
Price/Book (mrq) 0
Enterprise Value/Revenue -7.79
Enterprise Value/EBITDA 0.49
Overview
Shares outstanding 26.83M
Float 26.82M
Shares short 939.58K
% Held by insiders 0%
% Held by institutions 0.1%
Average volume (10 days) 48.06K
Average volume (90 days) 12.88K
Price summary
52-Week low 0
52-Week high 0.04
Beta 1.26
50-Day moving average 0
200-Day moving average 0
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 19 Sep 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2023
Most recent quarter (mrq) 30 Sep 2024
Profitability
Profit margin -16.56%
Operating margin -12.98%
Operational effectiveness
Return on assets -0.98%
Return on equity -2.28%
Income Statement
Revenue (ttm) 386K
Revenue per share (ttm) 0.35
Quarterly revenue growth (yoy) -
Gross profit (ttm) -88.25M
EBITDA -110.18M
Net income to common (ttm) -97.81M
Diluted EPS (ttm) -5.81
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 58.27M
Total cash per share (mrq) 4.93
Total debt (mrq) 60.23M
Total Debt/Equity (mrq) 3.73
Current ratio (mrq) 3.95%
Book value per share (mrq) 0.59
Cash Flow
Cash flow statement -100.02M
Levered free cash flow (LFCF) -57.94M
